CFGS
GSK icon

Concourse Financial Group Securities’s GSK GSK Stock Holding History

Concourse Financial Group Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,628
Closed -$54.4K – 874
2024
Q4 		$54.4K Sell
1,628
-4,830
-75% -$174K ﹤0.01% 1180
2024
Q3 		$266K Sell
6,458
-1,202
-16% -$49.2K 0.02% 619
2024
Q2 		$298K Sell
7,660
-1,003
-12% -$42.2K 0.02% 584
2024
Q1 		$375K Sell
8,663
-50
-0.6% -$2.06K 0.02% 503
2023
Q4 		$325K Buy
8,713
+4,591
+111% +$165K 0.02% 529
2023
Q3 		$151K Sell
4,122
-4,459
-52% -$158K 0.01% 706
2023
Q2 		$309K Sell
8,581
-1,231
-13% -$44.2K 0.02% 530
2023
Q1 		$352K Buy
9,812
+1,478
+18% +$51.7K 0.03% 500
2022
Q4 		$295K Sell
8,334
-691
-8% -$23K 0.02% 525
2022
Q3 		$269K Buy
9,025
+1,046
+13% +$39.6K 0.03% 470
2022
Q2 		$438K Buy
7,979
+1,454
+22% +$80.3K 0.04% 423
2022
Q1 		$360K Sell
6,525
-1,283
-16% -$69.7K 0.03% 499
2021
Q4 		$436K Buy
7,808
+265
+4% +$13.8K 0.02% 513
2021
Q3 		$365K Buy
7,543
+1,252
+20% +$62.9K 0.02% 539
2021
Q2 		$317K Buy
6,291
+1,364
+28% +$65.5K 0.02% 575
2021
Q1 		$224K Sell
4,927
-1,771
-26% -$80.4K 0.02% 648
2020
Q4 		$312K Buy
6,698
+9
+0.1% +$413 0.02% 486
2020
Q3 		$319K Buy
6,689
+1,275
+24% +$63.9K 0.03% 428
2020
Q2 		$279K Sell
5,414
-3,931
-42% -$202K 0.03% 431
2020
Q1 		$449K Buy
9,345
+159
+2% +$8.48K 0.05% 268
2019
Q4 		$544K Buy
9,186
+4,464
+95% +$248K 0.05% 269
2019
Q3 		$254K Sell
4,722
-3,294
-41% -$169K 0.06% 241
2019
Q2 		$401K Buy
8,016
+3,368
+72% +$169K 0.04% 303
2019
Q1 		$245K Buy
4,648
+354
+8% +$17.7K 0.03% 421
2018
Q4 		$207K Buy
4,294
+743
+21% +$36.6K 0.02% 422
2018
Q3 		$178K Buy
+3,551
New +$180K 0.05% 298

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Concourse Financial Group Securities's GSK Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of GSK (GSK) in Q1 2025, closing a stake of 1,628 shares — an estimated $54.4K sold.

Concourse Financial Group Securities first reported a position in GSK in Q3 2018 and held it in 26 quarters. The position peaked at $544K in Q4 2019. 858 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,628 GSK shares in Q1 2025, an estimated $54.4K.
  • Concourse Financial Group Securities first reported a position in GSK in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's GSK position peaked at $544K in Q4 2019.
  • 858 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.